AU1413997A - Use of rc-9 in diagnosis and treatment of proliferative arterial disease - Google Patents

Use of rc-9 in diagnosis and treatment of proliferative arterial disease

Info

Publication number
AU1413997A
AU1413997A AU14139/97A AU1413997A AU1413997A AU 1413997 A AU1413997 A AU 1413997A AU 14139/97 A AU14139/97 A AU 14139/97A AU 1413997 A AU1413997 A AU 1413997A AU 1413997 A AU1413997 A AU 1413997A
Authority
AU
Australia
Prior art keywords
diagnosis
treatment
arterial disease
proliferative
proliferative arterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14139/97A
Inventor
Anthony Joseph Arleth
Michael Victor Autieri
Eliot Howard Ohlstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU1413997A publication Critical patent/AU1413997A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU14139/97A 1995-12-18 1996-12-13 Use of rc-9 in diagnosis and treatment of proliferative arterial disease Abandoned AU1413997A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US880195P 1995-12-18 1995-12-18
US008801 1995-12-18
PCT/US1996/019671 WO1997022880A1 (en) 1995-12-18 1996-12-13 Use of rc-9 in diagnosis and treatment of proliferative arterial disease

Publications (1)

Publication Number Publication Date
AU1413997A true AU1413997A (en) 1997-07-14

Family

ID=21733759

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14139/97A Abandoned AU1413997A (en) 1995-12-18 1996-12-13 Use of rc-9 in diagnosis and treatment of proliferative arterial disease

Country Status (5)

Country Link
EP (1) EP0904543A1 (en)
JP (1) JP2000503764A (en)
AU (1) AU1413997A (en)
WO (1) WO1997022880A1 (en)
ZA (1) ZA9610584B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0879883A1 (en) * 1997-05-22 1998-11-25 Smithkline Beecham Corporation ATG-1120 (AIF-1-DELTA), a splice variant of AIF-1/RC-9
EP0879882A1 (en) * 1997-05-22 1998-11-25 Smithkline Beecham Corporation ATG-1100 (AIF-1-Gamma), a splice variant of AIF-1/RC-9
US20040132035A1 (en) * 2001-02-07 2004-07-08 Daemen Matthias Joseph A P Markers of unstable atherosclerotic plaques
EP2319924B1 (en) 2008-08-15 2016-03-09 Fujikura Kasei Co., Ltd. Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis

Also Published As

Publication number Publication date
EP0904543A1 (en) 1999-03-31
ZA9610584B (en) 1997-06-23
JP2000503764A (en) 2000-03-28
WO1997022880A1 (en) 1997-06-26

Similar Documents

Publication Publication Date Title
AU7230196A (en) Pskh-1 ribozymes and uses in disease treatment
AU4054297A (en) Manipulations of nitrosative and oxidatives stress in the treatment of disease
AU7605396A (en) Cannula with associated filter and methods of use during cardiac surgery
AU5687896A (en) Use of alpha 1L-agonists in the treatment of incontinence
HU9602583D0 (en) Gel for treatment of skin diseases and for disinfection of the skin
AU1688495A (en) Reproduction and utilization of functional human tissue
AU7721796A (en) Skin care preparation and method
AU2990695A (en) Mucin-derived proteins for the diagnosis, imaging, and therapy of human cancer
AU6813694A (en) Use of green porphyrins in ocular diagnosis and therapy
EP0831793A4 (en) Protein particles for therapeutic and diagnostic use
AU4713497A (en) Use of hollow microcapsules in diagnosis and therapy
AU1413997A (en) Use of rc-9 in diagnosis and treatment of proliferative arterial disease
AU6822796A (en) T-pa polymorphism and use thereof in diagnosis of risk of thrombus associated disease
AU7316196A (en) Diagnosis of susceptibility to cancer and treatment thereof
GB9514816D0 (en) Substances and their medical use
AU6777596A (en) Treatment of human prostate disease with beta-lapachone derivatives
AU4841296A (en) Diagnosis of and compositions and methods for the treatment of disease
AU1408999A (en) Detection and treatment of retinal degenerative disease
EP0862442A4 (en) Methods for diagnosis and treatment of bloom's syndrome
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
AU6852896A (en) Diagnosis and treatment of neurological disease
AU5929896A (en) Apparatuses and methods for treatment of blood
GB9520159D0 (en) Benzoioc amide retinoids for use in the treatment of skin diseases and cancer
AU5778098A (en) Therapeutic substance for use in the treatment of aids and immuno-allergical diseases
GB9406577D0 (en) Diagnosis and treatment of degenerative disease